Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is N/A as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-06-30): -18.02%.
NET PROFIT MARGIN
N/A
NET PROFIT MARGIN AVG TTM
-33.18%
NET PROFIT MARGIN AVG 3Y
-32.63%
NET PROFIT MARGIN AVG 5Y
-31.30%
NET PROFIT MARGIN AVG 10Y
-15.69%
NET PROFIT MARGIN AVG 15Y
-5.52%
NET PROFIT MARGIN AVG 20Y
-0.38%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Lifecore Biomedical, Inc.
Market Cap
$243.81M
Net Profit Margin
N/A
TTM Avg
-33.18%
3Y Avg
-32.63%
5Y Avg
-31.30%
Market Cap
$243.66M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$241.56M
Net Profit Margin
-155582.08%
TTM Avg
-91683.52%
3Y Avg
-62749.43%
5Y Avg
-41832.95%
Market Cap
$239.06M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$244.74M
Net Profit Margin
-2543.74%
TTM Avg
-5120.97%
3Y Avg
-6084.02%
5Y Avg
-4060.63%
Market Cap
$240.50M
Net Profit Margin
-26.97%
TTM Avg
-50.02%
3Y Avg
-94.39%
5Y Avg
-87.59%
Market Cap
$240.76M
Net Profit Margin
-4.52%
TTM Avg
-4.68%
3Y Avg
-9.38%
5Y Avg
-10.81%
Market Cap
$236.90M
Net Profit Margin
-13.54%
TTM Avg
-22.79%
3Y Avg
-26.12%
5Y Avg
-61.39%
Market Cap
$249.41M
Net Profit Margin
-183.90%
TTM Avg
-383.83%
3Y Avg
-191.92%
5Y Avg
-127.94%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lifecore Biomedical, Inc. (LFCR) | $243.81M | N/A | -33.18% | -32.63% | -31.30% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.66M | 0.00% | 0.00% | 0.00% | 0.00% |
| InflaRx N.V. (IFRX)vs › | $241.56M | -155582.08% | -91683.52% | -62749.43% | -41832.95% |
| Galectin Therapeutics Inc. (GALT)vs › | $239.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $244.74M | -2543.74% | -5120.97% | -6084.02% | -4060.63% |
| Biodesix, Inc. (BDSX)vs › | $240.50M | -26.97% | -50.02% | -94.39% | -87.59% |
| High Tide Inc. (HITI)vs › | $240.76M | -4.52% | -4.68% | -9.38% | -10.81% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $236.90M | -13.54% | -22.79% | -26.12% | -61.39% |
| Invivyd, Inc. (IVVD)vs › | $249.41M | -183.90% | -383.83% | -191.92% | -127.94% |
| BioAge Labs Inc. (BIOA)vs › | $234.93M | -912.25% | -448.06% | -224.03% | -224.03% |
Operating Margin
N/A
Net Profit Margin
N/A
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -18.02% |
| 2026-06-30 | -18.02% |
| 2026-03-31 | -64.59% |
| 2025-09-30 | -32.12% |
| 2025-05-25 | -3.15% |
| 2025-02-23 | -42.01% |
| 2024-11-24 | -20.18% |
| 2024-08-25 | -65.70% |
| 2024-05-26 | -18.70% |
| 2024-02-25 | 43.78% |
| 2023-11-26 | 47.16% |
| 2023-08-27 | -43.85% |
| 2023-05-28 | -139.38% |
| 2023-02-26 | -137.58% |
| 2022-11-27 | -58.57% |
| 2022-08-28 | -46.22% |
| 2022-05-29 | -76.98% |
| 2022-02-28 | -34.99% |
| 2021-11-30 | -88.47% |
| 2021-08-31 | -22.76% |
| 2021-05-31 | -2.05% |
| 2021-02-28 | -12.30% |
| 2020-11-30 | -10.16% |
| 2020-08-31 | -8.11% |
| 2020-05-31 | -9.70% |
| 2020-02-29 | -7.53% |
| 2019-11-30 | -4.73% |
| 2019-08-31 | -3.45% |
| 2019-05-31 | -0.17% |
| 2019-02-28 | 0.69% |
| 2018-11-30 | -0.47% |
| 2018-08-31 | 0.15% |
| 2018-05-31 | 4.33% |
| 2018-02-28 | 10.77% |
| 2017-11-30 | 0.36% |
| 2017-08-31 | 1.74% |
| 2017-05-31 | 1.92% |
| 2017-02-28 | 2.56% |
| 2016-11-30 | 0.98% |
| 2016-08-31 | 2.50% |
| 2016-05-31 | 3.49% |
| 2016-02-29 | -16.30% |
| 2015-11-30 | 1.33% |
| 2015-08-31 | 2.18% |
| 2015-05-31 | 3.12% |
| 2015-02-28 | 2.72% |
| 2014-11-30 | 2.43% |
| 2014-08-31 | 1.76% |
| 2014-05-31 | 3.76% |
| 2014-02-28 | 5.06% |
| 2013-11-30 | 2.88% |
| 2013-08-31 | 4.34% |
| 2013-05-31 | 4.22% |
| 2013-02-28 | 4.06% |
| 2012-11-30 | 7.77% |
| 2012-08-31 | 2.49% |
| 2012-05-31 | 3.36% |
| 2012-02-29 | 5.95% |
| 2011-11-30 | 4.09% |
| 2011-08-31 | 2.47% |
| 2011-05-31 | -4.02% |
| 2011-02-28 | 3.13% |
| 2010-11-30 | 2.93% |
| 2010-08-31 | 3.55% |
| 2010-05-31 | -2.52% |
| 2010-02-28 | 2.98% |
| 2009-11-30 | 2.52% |
| 2009-08-31 | 3.58% |
| 2009-05-31 | 4.32% |
| 2009-02-28 | 2.86% |
| 2008-11-30 | 2.58% |
| 2008-08-31 | 3.96% |
| 2008-05-31 | 5.89% |
| 2008-02-29 | 6.45% |
| 2007-11-30 | 5.30% |
| 2007-08-31 | 4.91% |
| 2007-05-31 | 8.63% |
| 2007-02-28 | 46.54% |
| 2006-11-30 | 0.20% |
| 2006-08-31 | 0.03% |
| 2006-05-31 | 9.39% |
| 2006-02-28 | 6.14% |
| 2005-11-30 | -1.93% |
| 2005-08-31 | -1.05% |
| 2005-05-31 | 8.21% |
| 2005-02-28 | 4.45% |
| 2004-11-30 | -1.59% |
| 2004-08-31 | -1.48% |
| 2004-05-31 | 7.30% |
| 2004-02-29 | 1.25% |
| 2003-11-30 | -3.66% |
| 2003-08-31 | -1.49% |
| 2003-04-30 | 8.03% |
| 2003-01-31 | -4.95% |
| 2002-10-31 | -7.06% |
| 2002-07-31 | -1.08% |
